BioLife Solutions Market Cap 2006-2018 | BLFS
BioLife Solutions market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. BioLife Solutions market cap as of March 25, 2019 is $0.35B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.350B | $0.020B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $137.409B | 27.16 |
| Medtronic (MDT) | Ireland | $121.535B | 17.77 |
| Stryker (SYK) | United States | $72.819B | 26.70 |
| Boston Scientific (BSX) | United States | $52.168B | 25.43 |
| Baxter (BAX) | United States | $39.788B | 25.45 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.879B | 16.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $14.802B | 0.00 |
| ResMed (RMD) | United States | $14.533B | 27.56 |
| Aurora Cannabis (ACB) | Canada | $9.364B | 66.07 |
| Bio-Rad Laboratories (BIO) | United States | $9.204B | 52.51 |
| Hill-Rom Holdings (HRC) | United States | $6.966B | 21.55 |
| Perrigo (PRGO) | Ireland | $6.355B | 10.30 |
| Insulet (PODD) | United States | $5.761B | 1943.60 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.977B | 0.00 |
| ICU Medical (ICUI) | United States | $4.744B | 29.53 |
| Haemonetics (HAE) | United States | $4.355B | 38.63 |
| Hutchison China MediTech (HCM) | China | $3.802B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.664B | 0.00 |
| Neogen (NEOG) | United States | $3.153B | 48.42 |
| NuVasive (NUVA) | United States | $2.938B | 25.63 |
| Quidel (QDEL) | United States | $2.527B | 22.80 |
| Aphria (APHA) | $2.418B | 107.33 | |
| National Vision Holdings (EYE) | United States | $2.298B | 45.20 |
| Cardiovascular Systems (CSII) | United States | $1.337B | 960.00 |
| HEXO (HEXO) | $1.317B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.274B | 24.95 |
| Phibro Animal Health (PAHC) | United States | $1.273B | 18.29 |
| AtriCure (ATRC) | United States | $1.095B | 0.00 |
| MacroGenics (MGNX) | United States | $0.957B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.914B | 24.70 |
| Cerus (CERS) | United States | $0.842B | 0.00 |
| Omeros (OMER) | United States | $0.836B | 0.00 |
| PetIQ (PETQ) | United States | $0.835B | 23.90 |
| NanoString Technologies (NSTG) | United States | $0.726B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.716B | 21.32 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.674B | 22.95 |
| OraSure Technologies (OSUR) | United States | $0.671B | 29.41 |
| TG Therapeutics (TGTX) | United States | $0.619B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.587B | 27.92 |
| Evolus (EOLS) | United States | $0.577B | 0.00 |
| Surmodics (SRDX) | United States | $0.556B | 80.90 |
| Quanterix (QTRX) | United States | $0.531B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.342B | 0.00 |
| Vapotherm (VAPO) | United States | $0.335B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.325B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.313B | 20.33 |
| Bovie Medical (APYX) | United States | $0.271B | 0.00 |
| Owens & Minor (OMI) | United States | $0.265B | 3.67 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.242B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.237B | 0.00 |
| Zynex (ZYXI) | United States | $0.142B | 15.21 |
| Fonar (FONR) | United States | $0.140B | 7.48 |
| Surface Oncology (SURF) | United States | $0.123B | 0.00 |
| Chimerix (CMRX) | United States | $0.103B | 0.00 |
| Female Health (VERU) | United States | $0.097B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.094B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.089B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 20.02 |
| CAS Medical Systems (CASM) | United States | $0.071B | 0.00 |
| Neurotrope (NTRP) | United States | $0.067B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.062B | 18.50 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.036B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.033B | 0.00 |
| Senestech (SNES) | United States | $0.032B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.015B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 15.14 |
